These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37162304)

  • 1. Generation of Synthetic
    Knauf GA; Groover KE; O'Donnell AC; Davies BW
    ACS Infect Dis; 2023 Jun; 9(6):1190-1195. PubMed ID: 37162304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.
    Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H
    J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inventory building of phages against extensively drug-resistant Acinetobacter baumannii isolated from wounds of patients with severe burn and related characteristic analysis].
    Yang ZC; Deng LY; Gong YL; Yin SP; Jiang B; Huang GT; Peng YZ; Hu FQ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):517-22. PubMed ID: 27647066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
    Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
    Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryo-EM Determination of Eravacycline-Bound Structures of the Ribosome and the Multidrug Efflux Pump AdeJ of Acinetobacter baumannii.
    Zhang Z; Morgan CE; Bonomo RA; Yu EW
    mBio; 2021 Jun; 12(3):e0103121. PubMed ID: 34044590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison Between Cell, Protein and Peptide-Based Approaches for Selection of Nanobodies Against CD44 from a Synthetic Library.
    Kavousipour S; Mokarram P; Gargari SLM; Mostafavi-Pour Z; Barazesh M; Ramezani A; Ashktorab H; Mohammadi S; Ghavami S
    Protein Pept Lett; 2018; 25(6):580-588. PubMed ID: 29848261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii.
    Hahm C; Chung HS; Lee M
    PLoS One; 2022; 17(3):e0264335. PubMed ID: 35245298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant
    Mujawar S; Mishra R; Pawar S; Gatherer D; Lahiri C
    Front Cell Infect Microbiol; 2019; 9():203. PubMed ID: 31281799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Virulent T4-Like
    Peters DL; Davis CM; Harris G; Zhou H; Rather PN; Hrapovic S; Lam E; Dennis JJ; Chen W
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to bacteriophage incurs a cost to virulence in drug-resistant
    Manley R; Fitch C; Francis V; Temperton I; Turner D; Fletcher J; Phil M; Michell S; Temperton B
    J Med Microbiol; 2024 May; 73(5):. PubMed ID: 38743467
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotyping of Acinetobacter baumannii strains isolated at a Japanese hospital over five years using targeted next-generation sequencing.
    Alshahni MM; Asahara M; Kawakami S; Fujisaki R; Matsunaga N; Furukawa T; Teramoto T; Makimura K
    J Infect Chemother; 2015 Jul; 21(7):512-5. PubMed ID: 25862195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii.
    Godeux AS; Lupo A; Haenni M; Guette-Marquet S; Wilharm G; Laaberki MH; Charpentier X
    J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012729
    [No Abstract]   [Full Text] [Related]  

  • 15. Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung.
    Wang N; Ozer EA; Mandel MJ; Hauser AR
    mBio; 2014 Jun; 5(3):e01163-14. PubMed ID: 24895306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.
    Dillon N; Holland M; Tsunemoto H; Hancock B; Cornax I; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2019 Aug; 46():193-201. PubMed ID: 31353294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a VHH targeting the Acinetobacter baumannii cell surface protein CsuA/B.
    Lei EK; Ryan S; van Faassen H; Foss M; Robotham A; Baltat I; Fulton K; Henry KA; Chen W; Hussack G
    Appl Microbiol Biotechnol; 2023 Jul; 107(14):4567-4580. PubMed ID: 37284893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
    Uddin R; Masood F; Azam SS; Wadood A
    Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
    Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.